Cargando…

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes

OBJECTIVE: The aim of this study was to investigate the pharmacokinetic, pharmacodynamic and safety profile of the glucagon‐like peptide‐1 receptor agonist, lixisenatide, for the treatment of type 2 diabetes (T2D) in pediatric individuals. MATERIALS AND METHODS: In this Phase 1, multicenter, randomi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barrientos‐Pérez, Margarita, Hsia, Daniel S., Sloan, Lance, Nell, Haylene, Mungur, Ounisha, Hovsepian, Lionel, Schmider, Wolfgang, Spranger, Robert, Yang, Na, Niemoeller, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons A/S 2022
Materias:	Obesity/Insulin Resistance, Type 2 Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790255/ https://www.ncbi.nlm.nih.gov/pubmed/35411611 http://dx.doi.org/10.1111/pedi.13343

Ejemplares similares

Prevalence of different states of glucose intolerance in Sri Lankan children and adolescents with obesity and its relation to other comorbidities
por: Ciba, Iris, et al.
Publicado: (2020)

Household food insecurity is associated with diabetic ketoacidosis but not severe hypoglycemia or glycemic control in youth and young adults with youth‐onset type 2 diabetes
por: Reid, Lauren A., et al.
Publicado: (2022)

Rapid progression of type 2 diabetes and related complications in children and young people—A literature review
por: Barrett, Timothy, et al.
Publicado: (2020)

Association of three insulin resistance indices with hypertension and body weight among Uyghur adults in rural areas of Xinjiang, China
por: Mao, YiDan, et al.
Publicado: (2022)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

The Vildagliptin Experience — 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration
por: Foley, James E, et al.
Publicado: (2017)

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017)

Clinical Safety and Tolerability of Vildagliptin — Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance
por: Mathieu, Chantal, et al.
Publicado: (2017)

Substitution among milk and yogurt products and the risk of incident type 2 diabetes in the EPIC‐NL cohort
por: Stuber, J. M., et al.
Publicado: (2020)

Effects of potato resistant starch intake on insulin sensitivity, related metabolic markers and appetite ratings in men and women at risk for type 2 diabetes: a pilot cross‐over randomised controlled trial
por: Sanders, L. M., et al.
Publicado: (2020)

Accumulation of childhood adversities and type 1 diabetes risk: a register-based cohort study of all children born in Denmark between 1980 and 2015
por: Bengtsson, Jessica, et al.
Publicado: (2020)

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus
por: Ortiz-Martínez, Margarita, et al.
Publicado: (2022)

The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseases
por: Sethupathy, Praveen
Publicado: (2016)

β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians
por: Yabe, Daisuke, et al.
Publicado: (2015)

Health Effects of Fructose and Fructose-Containing Caloric Sweeteners: Where Do We Stand 10 Years After the Initial Whistle Blowings?
por: Tappy, Luc, et al.
Publicado: (2015)

The Janus Head of Oxidative Stress in Metabolic Diseases and During Physical Exercise
por: Pesta, Dominik, et al.
Publicado: (2017)

Beta-cell Insufficiency
por: Kalra, Sanjay, et al.
Publicado: (2017)

Type 2 Diabetes: Multiple Genes, Multiple Diseases
por: Udler, Miriam S.
Publicado: (2019)

Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients?
por: Yki-Järvinen, Hannele, et al.
Publicado: (2013)

Insulin as an Early Treatment for Type 2 Diabetes: ORIGIN or end of an old question?
por: Del Prato, Stefano, et al.
Publicado: (2013)

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
por: Reznik, Yves, et al.
Publicado: (2013)

Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?
por: Mosenzon, Ofri, et al.
Publicado: (2013)

Early Insulinization to Prevent Diabetes Progression
por: Raz, Itamar, et al.
Publicado: (2013)

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013)

Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial
por: Watada, Hirotaka, et al.
Publicado: (2020)

Systems Biology Approaches and Applications in Obesity, Diabetes, and Cardiovascular Diseases
por: Meng, Qingying, et al.
Publicado: (2012)

Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications
por: Peters, Sanne A. E., et al.
Publicado: (2015)

Glutamine Triggers and Potentiates Glucagon-Like Peptide-1 Secretion by Raising Cytosolic Ca(2+) and cAMP
por: Tolhurst, Gwen, et al.
Publicado: (2011)

Overlap of Endocrine Hormone Expression in the Mouse Intestine Revealed by Transcriptional Profiling and Flow Cytometry
por: Habib, Abdella M., et al.
Publicado: (2012)

Leptin Acts Independently of Food Intake to Modulate Gut Microbial Composition in Male Mice
por: Rajala, Michael W., et al.
Publicado: (2014)

Overexpression of the Adiponectin Receptor AdipoR1 in Rat Skeletal Muscle Amplifies Local Insulin Sensitivity
por: Patel, S. A., et al.
Publicado: (2012)

Impaired Musculoskeletal Response to Age and Exercise in PPARβ(−/−) Diabetic Mice
por: Fu, He, et al.
Publicado: (2014)

Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin
por: Seino, Y, et al.
Publicado: (2014)

Genetic Risk of Progression to Type 2 Diabetes and Response to Intensive Lifestyle or Metformin in Prediabetic Women With and Without a History of Gestational Diabetes Mellitus
por: Sullivan, Shannon D., et al.
Publicado: (2014)

The Reality of Type 2 Diabetes Prevention
por: Kahn, Richard, et al.
Publicado: (2014)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

A “Spoonful of Sugar” and the Realities of Diabetes Prevention!
por: Cefalu, William T.
Publicado: (2014)

Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
por: Bress, Adam P., et al.
Publicado: (2018)

Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes
por: Lamprea-Montealegre, Julio A., et al.
Publicado: (2018)

Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes?: Health Be Damned! Pour on the Sugar
por: Bray, George A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ih4ea67c5dc6j9l9ek8o41d35v